Rubicon Point Partners announced the acquisition of the headquarters campus of Shockwave Medical in Santa Clara, California, on behalf of Rubicon Point Fund II.
The property includes a 201,078 square foot, four-building research and development campus that is fully triple-net leased to Shockwave Medical, which is a wholly owned subsidiary of Johnson & Johnson.
Located at 5353 Betsy Ross Drive in the heart of Silicon Valley, the 12.86-acre campus serves as Shockwave Medical’s global headquarters and primary R&D hub. The property supports the company’s executive leadership and innovation operations and is situated near major technology companies, including Apple, NVIDIA, Dell Technologies, and Cisco.
Shockwave Medical specializes in Intravascular Lithotripsy (IVL), a minimally invasive technology for treating calcified cardiovascular disease. Johnson & Johnson acquired the company in May 2024.
According to Rubicon Point Partners, the acquisition marks the beginning of a broader investment initiative across the West Coast focused on mission-critical real estate assets leased to institutional-grade tenants in innovation-driven markets.
The company said the acquisition aligns with its strategy of investing in institutional-quality assets located in supply-constrained markets with long-term demand drivers tied to technology and innovation.
CBRE National Office Partners served as the exclusive advisor on the transaction.
KEY QUOTE:
“This is the beginning of a billion dollar investment strategy that we plan to deploy over the coming few years throughout the region. This acquisition represents the quality and caliber of assets we will continue to target: mission-critical real estate leased to world-class tenants in the most dynamic markets on the West Coast.”
Ani Vartanian, Co-Founder and Managing Partner, Rubicon Point Partners
